Showing results (661-670 of 5,044) with videos related to

Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|October 25, 2022
Longitudinal stability of JCV antibody index in Natalizumab treated people with multiple sclerosisM Gaughan, M Gilligan, I Patterson, et al.
Multiple Sclerosis and Related Disorders|September 18, 2022
Stages of brain volume loss and performance in the Brief International Cognitive Assessment for Multiple SclerosisYusei Miyazaki, Masaaki Niino, Eri Takahashi, et al.
Multiple Sclerosis and Related Disorders|September 18, 2022
Revisiting the antiviral theory to explain interferon-beta's effectiveness for relapsing multiple sclerosisNahad Sedaghat, Masoud Etemadifar
Multiple Sclerosis and Related Disorders|August 29, 2022
Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapiesCavid Baba, Sinem Ozcelik, Ergi Kaya, et al.
Multiple Sclerosis and Related Disorders|August 31, 2022
Different doses of Rituximab for the therapy of Neuromyelitis optica spectrum disorder: A systematic review and meta-analysisKenhui Wei, Qianqian Nie, Yunfei Zhu, et al.
Multiple Sclerosis and Related Disorders|January 11, 2022
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemicElle Levit, Inessa Cohen, Megan Dahl, et al.
Multiple Sclerosis and Related Disorders|November 18, 2023
The association between sleep disorders and resilience in persons with multiple sclerosisKaitlin E Riegler, John Beauvais, Lindsay O Neto, et al.
Multiple Sclerosis and Related Disorders|November 21, 2023
Impairment of daily occupations in multiple sclerosis: analysis of neuroimaging, general and social cognition, and reserveLeticia Rodrigues Gomes, Benito Pereira Damasceno, Brunno Machado de Campos, et al.
Multiple Sclerosis and Related Disorders|December 1, 2023
Exploratory 5-year follow-up study of retinol, tocopherols, and carotenoids in multiple sclerosisNasim Nehzat, Richard W Browne, Diala Ghazal, et al.
Pageof 505